← All organizations
Highest phase reached
Phase 2
First clinical trial
Jan 1, 2008Last known activity
Sep 30, 2025
Defunct as of Jul 5, 2012
Timeline
1990s
- Jun 1, 1997
Biolex Therapeutics— Founded
2000s
- May 7, 2004
Epicyte Pharmaceuticals— Acquired
- Jul 28, 2005
LemnaGene— Acquired
2010s
- Jul 5, 2012
Biolex Therapeutics— Defunct
Drugs by trial phase (4 distinct, 5 trials)
Phase 2 (2 own, 0 via acquisition)
Indications
Subsidiaries (2 direct, 2 total across the full acquisition tree)
Recent trials (8)
- NCT07140055Lead sponsorPhase 1Sep 30, 2025
- NCT07140081Lead sponsorPhase 1Sep 30, 2025
- NCT00953589Study directorPhase 2Jul 1, 2009
- NCT00953589Lead sponsorPhase 2Jul 1, 2009
- NCT00863239Lead sponsorPhase 2Mar 1, 2009
- NCT00863239Study directorPhase 2Mar 1, 2009
- NCT00593151Study directorPhase 1/Phase 2Jan 1, 2008
- NCT00593151Lead sponsorPhase 1/Phase 2Jan 1, 2008
Details
- Founded
- Pittsboro, NC, US Jun 1, 1997
- Last known activity
- Sep 30, 2025